Literature DB >> 34697162

Combination of the CD8+:B-cell and Neutrophil-to-Lymphocyte Ratio as a Novel Prediction Model for Intubation Need and Disease Severity in COVID-19 Patients.

Maria G Detsika1, Eirini Grigoriou2, Katherina Psarra2, Edison Jahaj1, Stamatios Tsipilis1, Nikolaos Athanassiou1, Alexandros Zacharis1, Ioanna Dimopoulou1, Stylianos E Orfanos1, Alexandra Tsirogianni2, Anastasia Kotanidou3.   

Abstract

BACKGROUND: The study provides a novel prediction model for COVID-19 progression and outcome by the combination of the CD8+: B-cells ratio with neutrophil-to-lymphocyte ratio (NLR). PATIENTS AND METHODS: Immune phenotyping was performed in 120 COVID-19 patients.
RESULTS: A decrease in CD8+:B-cell (p<0.0001) and in lymphocyte-to-CRP (LCR) ratio (p<0.0001) was observed in intubated patients versus non-intubated with an increase for CD4+:CD8+ (p<0.01), NLR (p<0.0001) and CRP: Albumin (p<0.001). Receiving operating curve (ROC) analysis predicting requirement for mechanical ventilation revealed the highest AUC for CD8+:B-cells, (AUC=0.795, p<0.001) versus NLR (AUC=0.783, p<0.001), LCR (AUC=0.779, p<0.001), Albumin:CRP (AUC=0.750, p<0.001) and CD4+:CD8+ (AUC=0.779, p<0.001). Combination of the CD8+: B-cell ratio with the NLR increased the AUC (AUC=0.845, p<0.001). The combined ratios correlated with outcome defined as duration of hospital (r=0.435, p<0.001) or ICU stay (r=0.596, p<0.001).
CONCLUSION: Combination of the CD8+: B-cell ratio and NLR serves as a useful prognostic tool for COVID-19 patient progression.
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  COVID-19; SARS-COV-2; disease progression; immune phenotyping; intensive care unit; mechanical ventilation; prognostic markers

Mesh:

Year:  2021        PMID: 34697162      PMCID: PMC8627713          DOI: 10.21873/invivo.12626

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  18 in total

1.  Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study.

Authors:  Carlo Pallotto; Lorenzo Roberto Suardi; Sara Esperti; Roberto Tarquini; Elisa Grifoni; Simone Meini; Alice Valoriani; Stefania Di Martino; Francesco Cei; Eleonora Sisti; Fiorella Piani; Annarita Botta; Elena Salomoni; Filippo Baragli; Pierluigi Blanc
Journal:  Infect Dis (Lond)       Date:  2020-06-16

2.  Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.

Authors:  J M Urra; C M Cabrera; L Porras; I Ródenas
Journal:  Clin Immunol       Date:  2020-05-29       Impact factor: 3.969

3.  The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.

Authors:  Ai-Ping Yang; Jian-Ping Liu; Wen-Qiang Tao; Hui-Ming Li
Journal:  Int Immunopharmacol       Date:  2020-04-13       Impact factor: 4.932

4.  Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in severe COVID-19 patients.

Authors:  Aijia Ma; Jiangli Cheng; Jing Yang; Meiling Dong; Xuelian Liao; Yan Kang
Journal:  Crit Care       Date:  2020-06-05       Impact factor: 9.097

5.  Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.

Authors:  Jing Liu; Sumeng Li; Jia Liu; Boyun Liang; Xiaobei Wang; Hua Wang; Wei Li; Qiaoxia Tong; Jianhua Yi; Lei Zhao; Lijuan Xiong; Chunxia Guo; Jin Tian; Jinzhuo Luo; Jinghong Yao; Ran Pang; Hui Shen; Cheng Peng; Ting Liu; Qian Zhang; Jun Wu; Ling Xu; Sihong Lu; Baoju Wang; Zhihong Weng; Chunrong Han; Huabing Zhu; Ruxia Zhou; Helong Zhou; Xiliu Chen; Pian Ye; Bin Zhu; Lu Wang; Wenqing Zhou; Shengsong He; Yongwen He; Shenghua Jie; Ping Wei; Jianao Zhang; Yinping Lu; Weixian Wang; Li Zhang; Ling Li; Fengqin Zhou; Jun Wang; Ulf Dittmer; Mengji Lu; Yu Hu; Dongliang Yang; Xin Zheng
Journal:  EBioMedicine       Date:  2020-04-18       Impact factor: 8.143

6.  Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients.

Authors:  Inanc Karakoyun; Ayfer Colak; Melda Turken; Zeynep Altin; Fatma Demet Arslan; Veli Iyilikci; Nisel Yilmaz; Sukran Kose
Journal:  Int Immunopharmacol       Date:  2020-12-11       Impact factor: 5.714

7.  A novel ratio of CD8+:B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome.

Authors:  Maria G Detsika; Kleio Ampelakiotou; Eirini Grigoriou; Katherina Psarra; Edison Jahaj; Charis Roussos; Ioanna Dimopoulou; Stylianos E Orfanos; Alexandra Tsirogianni; Anastasia Kotanidou
Journal:  Virology       Date:  2021-01-13       Impact factor: 3.616

Review 8.  Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis.

Authors:  Wei Huang; Julie Berube; Michelle McNamara; Suraj Saksena; Marsha Hartman; Tariq Arshad; Scott J Bornheimer; Maurice O'Gorman
Journal:  Cytometry A       Date:  2020-07-18       Impact factor: 4.714

9.  Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.

Authors:  Francisco Alejandro Lagunas-Rangel
Journal:  J Med Virol       Date:  2020-04-08       Impact factor: 20.693

10.  High neutrophil-to-lymphocyte ratio associated with progression to critical illness in older patients with COVID-19: a multicenter retrospective study.

Authors:  Jiangshan Lian; Ciliang Jin; Shaorui Hao; Xiaoli Zhang; Meifang Yang; Xi Jin; Yingfeng Lu; Jianhua Hu; Shanyan Zhang; Lin Zheng; Hongyu Jia; Huan Cai; Yimin Zhang; Guodong Yu; Xiaoyan Wang; Jueqing Gu; Chanyuan Ye; Xiaopeng Yu; Jianguo Gao; Yida Yang; Jifang Sheng
Journal:  Aging (Albany NY)       Date:  2020-07-30       Impact factor: 5.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.